Clinical Pharmacology & Biopharmaceutics

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics

Preclinical safety evaluation of biopharmaceuticals

Search results for
Preclinical safety evaluation of biopharmaceuticals

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

pharmaceutical products are evaluated in humans, it is essential that they undergo a rigorous safety assessment using in vitro models and studies in preclinical species. Once products progress into the clinic, additional preclinical studies are needed to support further clinical testing. Although regulatory guidelines provide a good framework for the types of studies that should be performed, there are some areas where it is unclear how these should be applied to microbicides, what study designs should be used, whether certain tests are relevant or if additional assays are appropriate

Journals related to Preclinical safety evaluation of biopharmaceuticals 
Clinical Pharmacology & BiopharmaceuticsBiochemistry & Pharmacology: Open AccessAdvances in Pharmacoepidemiology & Drug SafetyJournal of Molecular Pharmaceutics & Organic Process Research, Biopharmaceutics & Drug Disposition, Pharmaceutical Sciences & Emerging Drugs, Journal of Pre-Clinical and Clinical Research, Austin Journal of Cancer and Clinical Research, European Journal of Clinical Pharmacy, Journal of Basic and Clinical Pharmacy.

Preclinical safety evaluation of biopharmaceuticals

Expert PPTs

Speaker PPTs

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings